Way back in 2014, Phase One teamed up with Alpa to create a truly, uh, unique “medium format mirrorless camera system” that was as weird as it was cool. I was fascinated by it. Since then, the company ...
Vigil Neuroscience reported positive Phase 1 trial results for VG-3927 and plans a Phase 2 trial in Q3 2025. Vigil Neuroscience, Inc. announced promising outcomes from a Phase 1 clinical trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results